Clin2
NCT04428801Possibly a fitNot yet recruiting

Stem cell treatment for people at high risk of COVID-19

COVID-19

Part of Infections, Lungs & breathing clinical trials.

This Phase 2 study tests whether donated-from-your-own-fat stem cells can improve outcomes for people who are high risk for getting COVID-19, but who have never had COVID-19 and test negative right now. It may help your immune system and reduce complications if you become infected during the study.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are age 18 or older and can sign informed consent
  • You already have your own stored stem cells from body fat at Celltex
  • You have no past COVID-19 and your breathing tests are negative for the virus now
  • Your blood tests for COVID-19 antibodies (IgM and IgG) are negative
  • You have high risk for COVID-19 infection (for example, very high BMI, certain blood pressure/diabetes, or long-term heart/lung/liver/kidney conditions—without being in the terminal stage)
  • You must not have recent participation in another drug study, recent major surgery/trauma, or conditions that strongly raise clotting/serious organ failure risk

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07664696Not yet recruiting· Phase 1/Phase 2
Stem cell medicine for COVID-19 symptoms

This trial tests a new medicine made from stem cells to see if it can help people with COVID-19 symptoms. It's for people who are overweight or moderately obese, have had symptoms for a few days, and have tested positive for COVID-19.

NCT05017298Not yet recruiting· Phase 2
Stem cell treatment for severe or critical COVID-19

This trial tests donated (allogeneic) fat-derived stem cells to see if they improve outcomes in adults with severe or critical COVID-19. It may help calm severe lung/immune problems, but whether it works and is safe will be studied in this Phase 2 study.

NCT06492798Recruiting· Phase 1/Phase 2
Stem cells for Long COVID: a safety and effectiveness study

This study tests whether a single infusion of mesenchymal stem cells can help with Long COVID symptoms—without causing serious side effects. It’s for people who are still struggling with COVID-related health problems months after their initial infection.

Shanghai
NCT04448106Not yet recruiting· Phase 2
Stem cell shot from your own fat for osteoarthritis pain

This Phase 2 study tests whether cells made from your own stored fat can improve osteoarthritis in your knee, hip, or shoulder. It’s for people who already have those fat-derived stem cells banked and who can safely follow the study plan.

Houston, Texas
NCT05939167Recruiting· Phase 1/Phase 2
Stem cell treatment study for people with late-stage HIV

This Phase 1/2 study tests whether mesenchymal stem cells can help people with HIV who have lower immune cell counts. You would join a treatment plan and follow study rules closely, while the researchers track safety and early signs of benefit.

Beijing
NCT07487467Recruiting
Stem cell therapy for type 2 diabetes

This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.

São Jose Do Rio Preto, São Paulo

Hear when a new COVID-19 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.